Tics
Studies from German Cancer Research Center, Division of Immunogenetics provide new data on tics
Published in Clinical Oncology Week, November 30th, 2009
Data detailed in 'FOXP3+CD25- tumor cells with regulatory function in Sezary syndrome' have been presented. "Cutaneous T-cell lymphoma (CTCL) has been suggested by in vitro experiments to represent a malignant CD4+ T-cell proliferation with a regulatory T-cell (Treg) phenotype (CD4+CD25+FOXP3+). We investigated percentages of FOXP3+ and CD25+ cells in the blood of 15 Sezary, 14 mycosis fungoides (MF), and 10 psoriasis (Pso) patients and 20 normal healthy donors (NHDs)," scientists writing in the Journal of Investigative Dermatology report.
"We found similar numbers of FOXP3+ cells in MF (10.4% of blood CD4+ cells) and Pso (11.1%) patients and NHDs (9.8%). In 8 of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Georgetown University Medical Center
For many, mammography every other year has benefits of annual screening, but less harm - JAMA and Archives Journals
Treatment with folic acid, vitamin B12 associated with increased risk of cancer, death - Journal of the National Cancer Institute
Bladder cancer risks increase over time for smokers - Journal of the National Cancer Institute
News brief: Adverse symptom reporting by patients vs. clinicians - The Wistar Institute
Wistar researchers show targeting 'normal' cells in tumors slows growth - University of California - Davis - Health System
Text message reminders can encourage healthy action - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
